DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Muromonab is an investigational drug.
There have been 10 clinical trials for Muromonab. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2011.
The most common disease conditions in clinical trials are Myelodysplastic Syndromes, Preleukemia, and Leukemia. The leading clinical trial sponsors are National Cancer Institute (NCI), Mayo Clinic, and University of California, Los Angeles.
Recent Clinical Trials for Muromonab
|Trial of Adoptive Immunotherapy With TRACT to Prevent Rejection in Living Donor Kidney Transplant Recipients||Northwestern University||Phase 1|
|Oral OKT3 for the Treatment of Active Ulcerative Colitis||Brigham and Women's Hospital||Phase 1/Phase 2|
|Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA Following Liver Transplantation||Novartis||Phase 4|